China CDC in Action - Hypertension Prevention and Control

Area of Science:

• Public Health
• Cardiovascular Disease Prevention
• Health Policy

Background:

• Hypertension is a significant contributor to mortality in China, accounting for a quarter of all deaths.
• The Chinese government and institutions like the China CDC are actively engaged in hypertension control efforts.
• Existing strategies include policy promotion, risk factor modification, and public health services for hypertension management.

Approach:

• The China Center for Disease Control and Prevention (China CDC) has led campaigns promoting salt reduction, weight loss, and physical activity.
• National demonstration areas for chronic disease control have been established, improving lifestyle, health literacy, and community-based hypertension management.
• The 'Healthy China 2030' initiative emphasizes a population-wide health focus over solely treating high-risk groups.

Key Points:

• The implementation of the 'Primary Health Care, Medicine and Health Promotion Law' on June 1, 2020, provides a legal framework for a new hypertension control strategy.
• The law supports a shift towards comprehensive prevention and control, integrating non-communicable diseases like hypertension into public health legislation.
• Established demonstration areas show improvements in population health literacy and community-based hypertension management.

Conclusions:

• China's approach to hypertension control is evolving towards a proactive, population-wide strategy supported by policy and legislation.
• The integration of hypertension prevention into broader public health and legislative frameworks is crucial for long-term success.
• Continued focus on modifiable risk factors and community-based management is essential for reducing hypertension-related mortality.